MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade

Immunity
March 1, 2016
Cited by 723Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis